Hangzhou AGS MedTech Co., Ltd. (SHA:688581)
China · Delayed Price · Currency is CNY 53.50
-0.34 (-0.63%)
At close: Aug 14, 2026
Hangzhou AGS MedTech Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 592.88 | 593.74 | 636.63 | 508.75 | 371.11 | 305.47 |
Revenue Growth | -12.17% | -6.74% | 25.14% | 37.09% | 21.49% | 77.64% |
Gross Profit Gross Profit Growth | 423.16 | 419.8 | 455.79 | 358.89 | 251.73 | 196.92 |
Operating Income Operating Income Growth | 204.29 | 210.68 | 282.11 | 218.72 | 150.1 | 117.09 |
Net Income Net Income Growth | 213.82 | 221.71 | 293.39 | 217.24 | 144.96 | 104.8 |
Earnings Per Share EPS Growth | 2.66 | 2.75 | 3.64 | 2.99 | 2.39 | 1.72 |
EPS Growth | -27.29% | -24.33% | 21.65% | 25.44% | 38.60% | 131.71% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Gi Gi Growth | 356.18 |
EMR/ESD Category EMR/ESD Category Growth | 156.86 |
ERCP ERCP Growth | 61.68 |
Medical Equipment Medical Equipment Growth | 13.29 |
Unallocated Other Unallocated Other Growth | 5.69 |
Total Total Growth | 593.71 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,977 | 1,966 | 1,784 | 2,037 | 268.4 | 205.62 |
Total Debt Total Debt Growth | 71.55 | 37.26 | 3.45 | 0.57 | 1.64 | 2.32 |
Net Cash (Debt) Net Cash Growth | 1,905 | 1,929 | 1,781 | 2,037 | 266.75 | 203.3 |
Net Cash Growth | 4.05% | 8.32% | -12.57% | 663.48% | 31.21% | 30.57% |
Net Cash Per Share Net Cash Per Share Growth | 23.66 | 23.97 | 22.10 | 28.06 | 4.39 | 3.35 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 218.98 | 151.2 | 315.8 | 221.45 | 156.38 | 118.25 |
Capital Expenditures CapEx Growth | -70.95 | -63.47 | -49.6 | -51.57 | -60.12 | -15.66 |
Free Cash Flow Free Cash Flow Growth | 148.03 | 87.74 | 266.19 | 169.88 | 96.26 | 102.59 |
Free Cash Flow Growth | -35.08% | -67.04% | 56.70% | 76.48% | -6.17% | 308.62% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 71.37% | 70.70% | 71.59% | 70.54% | 67.83% | 64.47% |
Operating Margin | 34.46% | 35.48% | 44.31% | 42.99% | 40.45% | 38.33% |
Pretax Margin | 42.45% | 44.14% | 53.97% | 49.47% | 44.61% | 39.27% |
Profit Margin | 36.06% | 37.34% | 46.09% | 42.70% | 39.06% | 34.31% |
FCF Margin | 24.97% | 14.78% | 41.81% | 33.39% | 25.94% | 33.59% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 1.039 | 1.039 | 1.373 | 1.036 | 0.543 |
Dividend Per Share Growth | -24.35% | -24.35% | 32.62% | 90.77% | - |
Dividend Yield | 1.93% | 1.81% | 2.40% | 1.23% | - |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 20.15 | 21.35 | 16.39 | 33.25 | - | - |
Forward PE | - | 13.09 | 15.01 | 29.08 | - | - |
P/FCF Ratio | 29.31 | 53.94 | 18.07 | 42.52 | - | - |
PS Ratio | 7.32 | 7.97 | 7.56 | 14.20 | - | - |